1. HBW Insight
  2. >>Archive

Organix Branding In Question Under Proposed Class-Action Settlement

 
• By Ryan Nelson

If approved, a class-action settlement between consumers and Vogue International will require the firm to elevate the organic content in its Organix brand or rename the line and stop characterizing it as organic in marketing. Qualifying purchasers of Organix products will be eligible for compensation under the proposed deal, according to a memorandum filed in California district court.

Tampa Bay, Fla.-based Vogue International will either have to rename its Organix brand of hair- and skin-care products and drop the word “organic” from promotional materials or boost the line’s organic content under a proposed settlement to a false-advertising suit filed by consumers in California.

In addition, the company will compensate qualifying purchasers of Organix products via payments from a $6

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Archive

More from HBW Insight

Beauty Industry Not Taking Advantage Of CBP’s Duty Drawback – IBA Conference

 
• By Eileen Francis

US Customs and Border Protection’s program allowing companies to recoup fees for imported goods that were destroyed or exported is applicable in the case of most of President Trump’s reciprocal tariffs. However, most cosmetic companies don’t make use of it.

Kennedy Defends Spending Cuts During Contentious Senate Hearing On HHS Budget

 
• By Elizabeth Orr

Health and Human Services Secretary Robert F. Kennedy Jr. emphasized administrative cost reductions and defended budget decisions during a Senate hearing on HHS funding. Some senators, however, expressed concerns over the impacts spending cuts had on essential health programs.

Recordati Relying On OTC To Act As ‘Booster’ To Growth

 
• By Tom Gallen

In categories like cough & cold and gastrointestinal, OTC products have a pivotal role to play in helping Recordati hit its sales targets for the 2025-2027 period.